-
-
-
-
-
-
-
Outlook Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Outlook Therapeutics Increases Previously Announced Bought Deal Offering of Common Stock to $35.0 Million
-
-
-
-
-
-
-
Outlook Therapeutics Announces $10.2 Million Financings Priced At-The-Market
70,832 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

